Enanta Pharmaceuticals Inc submits 10-K Annual Report

Enanta Pharmaceuticals Inc has submitted its 10-K Annual Report to the Securities and Exchange Commission. The filing includes 105 documents and covers the period ending on September 30, 2024. The 10-K form, along with other attachments such as EX-10.26 and EX-10.27, provide a comprehensive overview of the company’s financial performance, risk factors, and business outlook. The filing can be accessed through the following links:

– Link to 10-K document
– Link to EX-10.26 document
– Link to EX-10.27 document

Enanta Pharmaceuticals Inc is a company headquartered in Watertown, MA, specializing in pharmaceutical preparations. With a focus on life sciences, the company’s contact number is 617-607-0800. For more information about Enanta Pharmaceuticals Inc, you can visit their [official website](#) (website link not available).

To access the complete submission and review all 105 documents, you can refer back to the original SEC filing.